Resultados de la búsqueda 221-230 of 2471 for Assay
This study will compare the use of hypofraction proton therapy (28 treatments) alone to proton therapy with androgen suppression therapy. cfDNA Assay ...
The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early- ...
... assay. A database of paired clinical and sequencing data will also be established for future research. Numeración de páginas Estudios clínicos. Anterior ...
Eligible participants with mCRC will be enrolled into specific treatment arms based on their biomarker assay results. Numeración de páginas Estudios ...
... assay. A database of paired clinical and sequencing data will also be established for future research. The Pediatric Acute Leukemia (PedAL) Screening Trial ...
Rochester, Minn. The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals ...
Eligible participants with mCRC will be enrolled into specific treatment arms based on their biomarker assay results. A Phase I/II, open-label, multi-center ...
The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different anticoagulants. MC230818 ...
JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?